Angionicasp. z o.o.

Manufacture of irradiation, electromedical and electrotherapeutic equipment

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2015-05-07
Share capital
998,500.00 PLN
Activity description

Angionica develops a device for non-invasive diagnosis of vascular circulation disorders using the FMSF method. It measures changes in NADH fluorescence in the skin of the forearm in response to blood-flow restriction and release; the device won an award in the 23rd Polish Product of the Future competition.

Registered address
ul. Stefana Żeromskiego 114, 90-543 Łódź, Poland
Phone
Electronic delivery address
AE:PL-26602-60908-BFIJS-24

Financials

Revenue history (in k)

Filing timeliness

Financial statements were filed on time, on average 36 days early.

  • 202524/06/2026
  • 202427/06/2025
  • 202313/06/2024
  • 202220/06/2023
  • 202130/06/2022
  • 202030/06/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 16.40kMedianUSD 129.94kAverageUSD 1.98m
Net profit
This companyUSD -126.48kMedianUSD -472.34AverageUSD 146.18k
Operating costs
This companyUSD 136.17kMedianUSD 199.70kAverageUSD 1.73m
Assets
This companyUSD 112.39kMedianUSD 409.25kAverageUSD 2.27m

Offer

  • Circulation diagnostic device
  • Vascular diagnostics
  • NADH fluorescence measurement
Certifications: ISO 13485

Website technology

Analytics and marketing
  • Google Analytics

Public procurement

1 tender recorded as contractor, with a total value of $234.

SubjectAmount
Supply of laboratory and medical equipment in 4 lots for Gdański Uniwersytet Medyczny.
$234

Authorized Representatives

Ewa Gębicka Palka – Vice President of the Management Board
Jerzy Marian Gębicki – President of the Management Board

Manner of representation

In the event that a multi-member management board is appointed, each member of the management board is authorized independently to represent the company and make declarations of a proprietary and non-proprietary nature on its behalf.

Ownership

OwnerSharesShare valueStake
Ewa Maria Gębicka Palkaage 55
275$37,142.0913.7707%
Jerzy Marian Gębickiage 79
894$120,745.5444.7672%
Konrad Palkaage 56
663$89,546.1933.1998%
Others
165$22,285.258.2623%

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2015-05-21.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

4 public aid cases recorded, with a total value of $40,353.

PurposeGross amount
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
–
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
–
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
–

Competitors

Name
Brain Opticssp. z o.o.
Axonometrysp. z o.o.
NLA Systemssp. z o.o.
ScansoftS.A.
Nucleoticasp. z o.o.

Change history

DateEvent
2025-12-03Address change
2024-09-17Share capital increase
2022-11-29Address change
2019-11-29Share capital increase
2017-12-21Share capital increase

FAQ

Last updated: 2026-10-02